Decera Clinical Education Infectious Disease Podcast
Episodes
First Cohort With HIV: Paving the Path for the Future
06 Jul 2022
Contributed by Lukas
In this episode, hear HIV activist Marc Thompson share his perspectives on aging with HIV including: His early experiences after receiving his diagno...
Key Viral Hepatitis Studies Influencing My Practice Following EASL 2022—Audio Recap
06 Jul 2022
Contributed by Lukas
In this episode, Stefan Zeuzem, MD, discusses new viral hepatitis data from EASL 2022, including:Novel HBV therapeutics, including the REEF-2, B-Clear...
Advancements in Viral Hepatitis From EASL 2022
05 Jul 2022
Contributed by Lukas
In this episode, Nancy Reau, MD, discusses new viral hepatitis data from EASL 2022, including:Novel therapeutics for HBVTherapeutic vaccination for HB...
Defining and Striving for HBV Cure: What’s in the Pipeline
30 Jun 2022
Contributed by Lukas
In this episode, Carla S. Coffin, MD, MSc, shares her thoughts on the different investigational approaches under evaluation for their potential to a...
My Perspective: Living With HIV Is Life Changing but Not Life Limiting
21 Jun 2022
Contributed by Lukas
In this episode, Yvette Raphael provides her perspectives and advice as an individual living with HIV in South Africa for more than 20 years. She shar...
When Patients With Chronic HBV Infection Do Not Meet Indications for Immediate Treatment: The Critical Role of Ongoing Monitoring
26 May 2022
Contributed by Lukas
In this episode, Pietro Lampertico, MD, PhD, discusses what to do when treatment for hepatitis B virus (HBV) infection is not indicated, covering to...
Key Decisions in HIV Care: Postexposure Prophylaxis
26 May 2022
Contributed by Lukas
In this episode, Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS, explores the data and recommendations for HIV postexposure prophylaxis (PEP).List...
Key Decisions in HIV Care: Treatment Considerations for Transgender PWH
25 May 2022
Contributed by Lukas
In this episode, Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS, explores key considerations for transgender people with HIV (PWH).Listen as she gi...
Key Decisions in HIV Care: Choosing ART for Pediatric Patients
25 May 2022
Contributed by Lukas
In this episode, Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS, explores key considerations for choosing antiretroviral therapy (ART) for pediatri...
COVID-19: Outpatient Therapeutic Updates
24 May 2022
Contributed by Lukas
In this episode, Sharon R. Lewin, AO, FRACP, PhD, FAHMS, discusses: Principles for antiviral agent use in nonhospitalized patientsPreferred and alte...
RSV in Older Adults: Immunology and Vaccine Development
05 May 2022
Contributed by Lukas
In this episode, Dexter James Wiseman, MD, discusses immunology and RSV vaccine development for older adults, including:Need for a vaccineEconomic bur...
RSV in Older Adults: Epidemiology and Risk Factors
05 May 2022
Contributed by Lukas
In this episode, Dexter James Wiseman, MD, discusses the epidemiology and risk factors for RSV in older adults, including:OverviewDisease burden based...
RSV in Older Adults: Identification and Impact
05 May 2022
Contributed by Lukas
In this episode, Dexter James Wiseman, MD, discusses the impact and diagnosis of RSV in older adults, including:Risk factors for poor outcomesRSV vs i...
Adult HBV Vaccination: Current Vaccines and Vaccination Strategies
05 May 2022
Contributed by Lukas
In this episode, listen as Robert G. Gish, MD, discusses key information on comparing current HBV vaccine formulations, and learn the best immunizatio...
Adult HBV Vaccination: Identifying Individuals at Risk for Reduced Seroprotection
05 May 2022
Contributed by Lukas
In this episode, learn about the importance of identifying adults at risk for reduced hepatitis B virus (HBV) seroprotection and applying current HBV ...
Adult HBV Vaccination: Overcoming Gaps to Lessen the Burden and Impact of HBV
05 May 2022
Contributed by Lukas
In this episode, learn about the importance of hepatitis B virus (HBV) vaccination in adults. Listen as Robert G. Gish, MD, discusses key data on the ...
Increasing Awareness of Hepatitis Delta
03 May 2022
Contributed by Lukas
Hepatitis delta virus (HDV) is the most severe form of viral hepatitis, yet many patients go undiagnosed. Increasing HDV awareness is an important ste...
Why Everyone Should Be Screened for HCV and Treated If They Have It: Conversations Between Patient and Physician
03 May 2022
Contributed by Lukas
In this episode, Norah Terrault, MD, MPH, and a patient who has been cured of hepatitis C virus (HCV) infection discuss the importance of universal HC...
Key Decisions in HIV Care: Considering Novel Therapies for HIV
02 May 2022
Contributed by Lukas
In this episode from the series “Key Decisions in HIV Care,” Cristina Mussini, MD, and William R. Short, MD, MPH, AAHIVS, discuss novel therapies ...
A Model Intervention: Aiming for HCV Elimination in HIV-Positive MSM
27 Apr 2022
Contributed by Lukas
In this podcast, Dr Dominique Laurent Braun discusses his micro-elimination program, the Swiss HCVree trial, designed to prevent hepatitis C virus (HC...
COVID-19: Which Drug, When, and Why? Antiviral Agents
25 Apr 2022
Contributed by Lukas
Antiviral agents continue to be effective against different strains of SARS-CoV-2 when used early in the disease course. In this episode, learn about ...
COVID-19: Which Drug, When, and Why? Monoclonal Antibody Treatments
21 Apr 2022
Contributed by Lukas
The place of monoclonal antibodies in COVID-19 is changing. In this episode, learn about their role in prophylaxis of patients who are at high risk of...
How Stigma and Socioeconomic Barriers Impede HCV Care: Conversations Between Patient and Physician
20 Apr 2022
Contributed by Lukas
In this episode, Oluwaseun Falade-Nwulia, MBBS, MPH, and a patient with previous injection drug use who has been cured of HCV infection discuss critic...
Long COVID
13 Apr 2022
Contributed by Lukas
In this episode, Renslow Sherer, MD, discusses what is known to date regarding long COVID, also known as postacute sequelae of COVID-19 infection, inc...
Importance of Screening for HCC in HBV: Patient and Physician Sharing Session #7
12 Apr 2022
Contributed by Lukas
In episode 7 of a series of sharing sessions between a physician and patient, Ming-Lung Yu, MD, PhD, and his patient, who is living with chronic hepat...
COVID-19: Which Drug, When, and Why? Anti-inflammatory Agents and Immunomodulators
07 Apr 2022
Contributed by Lukas
Anti-inflammatory agents and immunomodulators are key components to treating patients who are severely or critically ill due to a COVID-19 infection.I...
Key Decisions in HIV Care: Managing ART With Opportunistic Infections
05 Apr 2022
Contributed by Lukas
In this episode from the series “Key Decisions in HIV Care,” Cristina Mussini, MD, and William R. Short, MD, MPH, AAHIVS, discuss important consid...
Hepatitis Delta a Major Global Problem: Screening, Diagnosis, and Treatment in 2022 – Physician Discussion #1
30 Mar 2022
Contributed by Lukas
In this episode, Heiner Wedemeyer, MD, discusses HDV epidemiology beyond the United States, the features of HDV/HBV pathology, insights into screeni...
The Ups and Downs of Living With HBV: Conversations Between Patient and Physician #4
25 Mar 2022
Contributed by Lukas
Episode 4 of this series features a conversation between a patient, Jason, and Paul Y. Kwo, MD, who discuss the particular challenges that can affect ...
Key Decisions in HIV Care: PrEP Considerations in Cisgender Men and Transgender Women
25 Mar 2022
Contributed by Lukas
In this episode from the series “Key Decisions in HIV Care,” Latesha Elopre, MD, MSPH, and Karine Lacombe, MD, PhD, discuss important consideratio...
Key Decisions in HIV Care: PrEP Considerations in Cisgender Women
24 Mar 2022
Contributed by Lukas
In this episode from the series “Key Decisions in HIV Care,” Latesha Elopre, MD, MSPH, and Karine Lacombe, MD, PhD, discuss important consideratio...
Lessons From Lockdown: HCC and Liver Transplant Care in the COVID-19 Era
23 Mar 2022
Contributed by Lukas
In this episode, Graham R. Foster, FRCP, PhD, and Paul Y. Kwo, MD, share lessons learned in the management of HCC and liver transplantation the COVID-...
Key Decisions in HIV Care: Considerations for Long-Acting Injectable PrEP
21 Mar 2022
Contributed by Lukas
In this episode, Jason Schafer, PharmD, MPH, explores key considerations for the use of long-acting injectable pre-exposure prophylaxis (PrEP).- Liste...
Rational Use of New and Emerging Agents for Hepatitis Delta Virus
16 Mar 2022
Contributed by Lukas
Hepatitis delta virus (HDV) is the most severe form of viral hepatitis and warrants new treatment options for better efficacy and tolerability. In par...
Conference Conversations: HIV Advanced Practice Provider Perspectives from CROI 2022
16 Mar 2022
Contributed by Lukas
In this episode, Jeffrey Kwong, DNP, MPH, FAANP, FAAN, and Susan LeLacheur, DrPH, PA-C, AAHIVS, share insights on new HIV data from CROI 2022, includi...
Conference Conversations: HIV Pharmacist Perspectives from CROI 2022
15 Mar 2022
Contributed by Lukas
In this episode, Fidelia Bernice, PharmD, and Jennifer Cocohoba, PharmD, share insights on new HIV data from CROI 2022, including:Islatravir tissue an...
HABP/VABP and Gram-Negative Resistance: Pathways to Early Effective Therapy
15 Mar 2022
Contributed by Lukas
In this episode, Keith S. Kaye, MD, MPH; Lilian Abbo, MD, FIDSA; and Jason M. Pogue, PharmD, discuss HABP/VABP and gram-negative resistance including:...
Lessons From Lockdown: Viral Hepatitis Testing and Treatment in the COVID-19 Era—Audio Recap
14 Mar 2022
Contributed by Lukas
In this episode, Jordan J. Feld, MD, MPH, and Nancy Reau, MD, share lessons learned in the testing and treatment of viral hepatitis in the COVID-19 er...
Key HIV Studies Influencing My Practice Following CROI 2022—Audio Recap
14 Mar 2022
Contributed by Lukas
In this episode, Daniel R. Kuritzkes, MD, and David A. Wohl, MD, discuss new HIV data from CROI 2022, including:Prevention strategiesLA therapiesSecon...
Key Decisions in HIV Care: ART Considerations in the Inpatient Setting
14 Mar 2022
Contributed by Lukas
In this episode, Jason Schafer, PharmD, MPH, explores recommendations and data on managing antiretroviral therapy (ART) in the inpatient setting.List...
Key Decisions in HIV Care: Data on Long-Acting Injectable PrEP
14 Mar 2022
Contributed by Lukas
In this episode, Jason Schafer, PharmD, MPH, explores the data for long-acting injectable pre-exposure prophylaxis (PrEP).Listen as he gives his pers...
Monitoring and Treating Patients Coinfected With HBV and HDV
10 Mar 2022
Contributed by Lukas
Hepatitis delta virus (HDV) only exists in patients with hepatitis B virus (HBV) coinfection. In part 1 of this 2-part podcast series, hear Heiner Wed...
Starting HBV Treatment in Pregnancy: Conversations Between Patient and Physician #3
07 Mar 2022
Contributed by Lukas
Episode 3 of this series features Anna Cristina L. dela Cruz, MD, in conversation with patient Melody Cheng about Melody’s decision to start hepatit...
Hepatitis Delta Treatment: Where We Are and Where We Are Headed
03 Mar 2022
Contributed by Lukas
Treatment options for hepatitis delta virus (HDV) are lacking, but many exciting agents are under investigation. Hear Drs Nancy Reau and Stefan Zeuzem...
How Can We Destigmatize a Hepatitis B Diagnosis? Conversations Between Patient and Physician #2
24 Feb 2022
Contributed by Lukas
In episode 2 of this series, tune in to a conversation between Robert G. Gish, MD, and patient advocate Jacki Chen, PhD, about the potential benefits ...
Lessons From Lockdown: Caring for Patients With Hepatitis B Virus Infection in the COVID-19 Era—Audio Recap
24 Feb 2022
Contributed by Lukas
In this episode, Drs Norah Terrault, MD, MPH, and Grace LH Wong, MD, share lessons learned in the care of patients with hepatitis B virus (HBV) in the...
COVID-19: Omicron Transmissibility, Severity, and Vaccine Effectiveness
22 Feb 2022
Contributed by Lukas
In this episode, Sharon R. Lewin, AO, FRACP, PhD, FAHMS, discusses what is known about the SARS-CoV-2 omicron variant, including:Transmissibility and ...
Importance of Treatment for HBV: Patient and Physician Sharing Session #6
18 Feb 2022
Contributed by Lukas
In episode 6 of an ongoing series of sharing sessions between a physician and patient, Tarik Asselah, MD, PhD, and his patient, who is living with chr...
Key Decisions in HIV Care: Treating HIV/HCV Coinfection
16 Feb 2022
Contributed by Lukas
In this episode, Mark S. Sulkowski, MD, explores recommendations and data on treating HIV and hepatitis C virus (HCV) in patients who are coinfected.L...
My Management Strategies for NASH in Patients With HIV
15 Feb 2022
Contributed by Lukas
In this episode, Mark S. Sulkowski, MD, discusses his recommended approach for managing nonalcoholic steatohepatitis in patients with HIV, including r...
Lessons From Lockdown: Hepatitis Delta Elimination Strategies in the COVID-19 Era
11 Feb 2022
Contributed by Lukas
In this episode, Robert G. Gish, MD, and Pietro Lampertico, MD, PhD, share lessons learned in the care of patients coinfected with hepatitis B virus a...
Key Decisions in HIV Care: Renal and Hepatic Considerations in Older PWH
10 Feb 2022
Contributed by Lukas
In this episode from the series “Key Decisions in HIV Care,” Jonathan Appelbaum, MD, FACP, AAHIVS, and Jens D. Lundgren, MD, DMSc, discuss importa...
Don’t Forget About the Liver! NASH in Patients with HIV: Answering the Questions Forum
09 Feb 2022
Contributed by Lukas
In this episode, Jürgen K. Rockstroh, MD, and Giada Sebastiani, MD, discuss key strategies to appropriately screen for, identify, and manage nonalcoh...
NASH in PWH: Key Strategies for Screening and Identification
03 Feb 2022
Contributed by Lukas
In this episode, Jürgen K. Rockstroh, MD, discusses his recommended approach for diagnosing nonalcoholic steatohepatitis in patients with HIV, the va...
Key Decisions in HIV Care: Considering the Use of Proviral DNA Genotyping to Inform ART Choice
01 Feb 2022
Contributed by Lukas
In this episode, John D. Baxter, MD, explores recommendations and data on the use of proviral DNA genotyping to inform antiretroviral therapy (ART) ch...
Tackling Racial Inequities in HIV Care Globally
26 Jan 2022
Contributed by Lukas
In this episode, Rageshri Dhairyawan, MBBS, BSc, FRCP, DipGUM, DFSRH, DipHIV, and Solange L. Baptiste, ScM, discuss the burden of HIV among BIPOC and ...
Key Decisions in HIV Care: Choosing Initial ART in PWH With Transmitted Drug Resistance
25 Jan 2022
Contributed by Lukas
In this episode, John D. Baxter, MD, explores recommendations and data on choosing antiretroviral therapy with transmitted drug resistance.Listen as ...
Omicron Variant: Effects on Treatments for COVID-19
25 Jan 2022
Contributed by Lukas
The SARS-CoV-2 omicron variant has affected which of our COVID-19 treatment strategies are currently effective, with some expected to maintain their e...
Tackling Racial Inequities in HIV Care in the United States
12 Jan 2022
Contributed by Lukas
In this episode, Samantha V. Hill, MD, MPH, and David Malebranche, MD, MPH, examine key facilitators to tackling racial inequities in HIV care, includ...
Key Decisions in HIV Care: ART Considerations With Coinfections
10 Jan 2022
Contributed by Lukas
In this episode from the series “Key Decisions in HIV Care,” Daria Podlekareva, MD, PhD, and Mark S. Sulkowski, MD, discuss important consideratio...
Key Decisions in HIV Care: Is There a Role for PIs in Current Practice?
06 Jan 2022
Contributed by Lukas
In this episode, Karen Ha, MD, explores recommendations and data on the role of PIs in current practice.Listen as she gives her perspectives on:DHHS g...
COVID-19 Oral Antiviral Agents
06 Jan 2022
Contributed by Lukas
In this episode, Renslow Sherer, MD, discusses key data on COVID-19 oral antiviral agents—molnupiravir and nirmatrelvir (PF-07321332) plus ritonavir...
Key Decisions in HIV Care: Is There a Role for NNRTIs in Current Practice?
06 Jan 2022
Contributed by Lukas
In this episode, Karen Ha, MD, explores recommendations and data on the role of NNRTIs in current practice.Listen as she gives her perspectives on:DH...
Personal Perspectives on HIV PrEP Use: My Decision, My Experience
03 Jan 2022
Contributed by Lukas
In this episode, Christian R. Pollard provides his perspectives as an individual taking daily oral HIV PrEP, including factors he considered in the de...
Key Decisions in HIV Care: Choosing ART in the Context of Virologic Failure and Resistance
29 Dec 2021
Contributed by Lukas
In this episode from the series “Key Decisions in HIV Care,” W. David Hardy, MD, and Josep M. Llibre, MD, PhD, discuss important considerations fo...
Individualized Choices in Antiretroviral Therapy: Present and Future
21 Dec 2021
Contributed by Lukas
Hear insights from 3 faculty experts as they present emerging data and guidelines and engage in discussion on patient-centered ART selection for peopl...
Key Decisions in HIV Care: Polypharmacy and Cardiovascular Risk Considerations in Older PWH
21 Dec 2021
Contributed by Lukas
In this episode from the series “Key Decisions in HIV Care,” Jonathan Appelbaum, MD, FACP, AAHIVS, and Jens D. Lundgren, MD, DMSc, discuss importa...
Universal Screening for Hepatitis Delta
20 Dec 2021
Contributed by Lukas
Hepatitis delta is the most severe form of viral hepatitis, and many patients remain undiagnosed. In this episode, Maria Buti, MD, and Robert G. Gish,...
Key Decisions in HIV Care: Assessing Candidacy for Long-Acting ART
16 Dec 2021
Contributed by Lukas
In this episode, Milena Murray, PharmD, MSc, BCIDP, AAHIVP, explores recommendations and data on patient specific factors associated with LA CAB plus...
Tackling Racial Inequalities in HBV Care Globally
15 Dec 2021
Contributed by Lukas
In this episode, Geoffrey Dusheiko, FRCP, FRCP (Edin), FCP (SA), and Ming-Lung Yu, MD, PhD, discuss key racial inequities of care that lead to under...
Shingles in the COVID-19 Era: Increasing Shingles Vaccine Uptake—Audio Recap
14 Dec 2021
Contributed by Lukas
In this episode, Dalilah Restrepo, MD, discusses barriers to shingles vaccination and strategies to increase routine vaccine uptake in the COVID-19 er...
COVID-19 Vaccination: Third Doses and Boosters
10 Dec 2021
Contributed by Lukas
In this episode, Renslow Sherer, MD, discusses key data on COVID-19 vaccine efficacy, including:Third dosesBooster dosesMixing and matching booster do...
Key Studies on Vaccine-Preventable Diseases Influencing My Practice Following IDWeek 2021
06 Dec 2021
Contributed by Lukas
In this episode, Martin C. Mahoney, MD, PhD, discusses new data on vaccine-preventable diseases from IDWeek 2021, including:Pneumococcal diseaseRespir...
Key Viral Hepatitis Studies Influencing My Practice Following AASLD 2021
01 Dec 2021
Contributed by Lukas
In this episode, Nancy Reau, MD, discusses new viral hepatitis data from AASLD 2021, including:HBV treatment in pregnancyOutcomes following HBV treatm...
Key Studies Influencing My Practice Following EACS 2021—Audio Recap
30 Nov 2021
Contributed by Lukas
In this episode, Tristan J. Barber, MA, MD, FRCP, discusses new HIV data from EACS 2021, including:First-line therapiesBIC/FTC/TAF in a test-and-treat...
Shingles in the COVID-19 Era: Vaccination for Prevention of Complications—Audio Recap
23 Nov 2021
Contributed by Lukas
In this episode, Dalilah Restrepo, MD, discusses expert guidance on vaccination for the prevention of shingles complications in the COVID-19 era.Contr...
Key Decisions in HIV Care: Managing Suboptimal CD4+ Cell Count Increase Despite Suppressive ART
19 Nov 2021
Contributed by Lukas
In this episode, William R. Short, MD, MPH, AAHIVS, explores recommendations and data on strategies to address suboptimal CD4+ cell count response in...
Tackling Racial Disparities in HCV Care: Global Edition
17 Nov 2021
Contributed by Lukas
In this episode, Prof Ashley Brown, BSc, MD, FRCP, and Ahmed M. Elsharkawy, PhD, FRCP(UK), discuss key racial inequities of care that lead to undertre...
Emerging Insights on Adverse Events During ART and Implications for Treatment: Nephrotoxicity and Long-Acting Injectables
16 Nov 2021
Contributed by Lukas
In this episode, Fidelia Bernice, PharmD, and Aadia I. Rana, MD, share insights on HIV ART safety and tolerability including recent data on nephrotoxi...
Shingles in the COVID-19 Era: Shingles Vaccination Guidelines—Audio Recap
11 Nov 2021
Contributed by Lukas
In this episode, Tracy Zivin-Tutela, MD, discusses expert guidance on vaccination against shingles.Tracy Zivin-Tutela, MDInfectious Diseases Specialis...
Key Decisions in HIV Care: Switching to a 2-Drug Single-Tablet Regimen
10 Nov 2021
Contributed by Lukas
In this episode, William R. Short, MD, MPH, AAHIVS, explores recommendations and data on switching to 2-drug single-tablet ART regimens.Listen as he g...
Lessons From Lockdown: Perspectives on Hepatitis C Care in the US and Australia—Audio Recap
10 Nov 2021
Contributed by Lukas
In this episode, Gregory Dore, MBBS, PhD, FRACP, MPH, and Stacey Trooskin, MD, PhD, MPH, share lessons learned in the care of patients with HCV infect...
Should We Screen Patients With HIV for NAFLD/NASH?
10 Nov 2021
Contributed by Lukas
In this episode, hepatologist Giada Sebastiani, MD, discusses why the presence of obesity, metabolic syndrome, persistent elevation of ALT, or exposur...
Key Decisions in HIV Care: ART in Pregnancy
08 Nov 2021
Contributed by Lukas
In this episode from the series “Key Decisions in HIV Care,” Milena Murray, PharmD, MSc, BCIDP, AAHIVP, and Jonah Musa, MBBS, MSCI, PhD, discuss i...
Key COVID-19 Studies Influencing My Practice Following IDWeek 2021—Audio Recap
29 Oct 2021
Contributed by Lukas
In this episode, Renslow Sherer, MD, discusses new COVID-19 data from IDWeek 2021, including:Prevention of COVID-19ChAdOx1 nCoV-19Ad26.COV2.STixagevim...
Racial Disparities in COVID-19: Causes, Consequences, and Clinical Strategies—Audio Recap
29 Oct 2021
Contributed by Lukas
In this episode, Oni Blackstock, MD, MHS, and Nina T. Harawa, PhD, MPH, discuss racial disparities in COVID-19 outcomes, including:Background on healt...
The Promise of Individualized HIV Prevention: Future Formulations and Dosing Intervals for Long-Acting PrEP
21 Oct 2021
Contributed by Lukas
In this episode, Nicholas Chamberlain, MD, provides an overview of the different antiretroviral drug formulations and dosing strategies in various sta...
A Long Journey to HCV Cure: Conversations Between Patient and Physician #1
19 Oct 2021
Contributed by Lukas
In episode 1 of an ongoing series of conversations between a physician and patient, Stacey Trooskin, MD, PhD, MPH, and patient advocate Brother Dan Pa...
New COVID-19 Data: A Case for Optimism?
14 Oct 2021
Contributed by Lukas
In this podcast episode, Paul E. Sax, MD, and Renslow Sherer, MD, discuss the clinical significance of new data on the prevention and treatment of COV...
Key Decisions in HIV Care: What to Do About Missed CAB + RPV LA Injections?
13 Oct 2021
Contributed by Lukas
In this episode, Milena Murray, PharmD, MSc, BCIDP, AAHIVP, explores recommendations and data to support the management of missed CAB plus RPV inject...
Key Decisions in HIV Care: Considerations for Maternal Weight Gain
12 Oct 2021
Contributed by Lukas
In this episode, Milena Murray, PharmD, MSc, BCIDP, AAHIVP, explores recommendations and data on maternal weight gain associated with ART use in preg...
Key HIV Studies Influencing My Practice Following IDWeek 2021 – Audio Recap
11 Oct 2021
Contributed by Lukas
In this episode, Darcy Wooten, MD, discusses new HIV data from IDWeek 2021, including:A rapid test-and-treat program to start DTG/3TC in patients newl...
Audio Recap: Timely Treatment for COVID-19
11 Oct 2021
Contributed by Lukas
During this episode, Lynora Saxinger, MD, FRCPC, CTropMed, updates listeners on the latest Emergency Use Authorizations and guideline recommendations ...
Key Decisions in HIV Care: Rapid Initiation of ART
29 Sep 2021
Contributed by Lukas
In this episode from the series “Key Decisions in HIV Care,” Jason Halperin, MD, MPH, and Jürgen K. Rockstroh, MD, discuss important consideratio...
Key Decisions in HIV Care: Tenofovir Alafenamide in Pregnancy
29 Sep 2021
Contributed by Lukas
In this episode, Milena Murray, PharmD, MSc, BCIDP, AAHIVP, explores the data to support the use of tenofovir alafenamide in pregnancy.Listen as she g...
Shingles in the COVID-19 Era: Risk Factors and Complications—Audio Recap
24 Sep 2021
Contributed by Lukas
In this episode, Tracy Zivin-Tutela, MD, discusses factors that put your patients at risk for shingles and its complications.Tracy Zivin-Tutela, MDInf...
Key Decisions in HIV Care: Considering Rapid ART in a Patient With Opioid Use Disorder
23 Sep 2021
Contributed by Lukas
In this episode, Jason Halperin, MD, MPH, explores the data to support rapid ART initiation in patients with OUD.Listen as he gives his perspectives o...
Key Decisions in HIV Care: Initiating Timely ART in a Newly Diagnosed Adolescent
23 Sep 2021
Contributed by Lukas
In this episode, Jason Halperin, MD, MPH, explores the data to support rapid ART initiation in adolescent patients.Listen as he gives his perspectives...
Emerging Long-Acting PrEP Options
16 Sep 2021
Contributed by Lukas
In this episode, Colleen Kelley, MD, MPH, discusseskey features and available safety and efficacy data on investigational long-acting HIV pre-exposure...
Contemporary Management of HIV 2021: New Data From IAS 2021—Audio Recap, Part 2
14 Sep 2021
Contributed by Lukas
In this second of 2 episodes, Shobha Swaminathan, MD, and Eric S. Daar, MD, review key data influencing their practice following the IAS 2021 Conferen...